Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G1B | P04054 | 1/20 | 0.60 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.60 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.59 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.59 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.59 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.59 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.52 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | THPO | P40225 | 1/20 | 0.48 |
| ▸ | MTOR | P42345 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8980542 | 1.00 | PLA2G1B (0.60) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL5500934 | 1.00 | PLA2G1B (0.60) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL6645242 | 1.00 | PLA2G1B (0.60) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL7610788 | 1.00 | PLA2G1B (0.60) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL6644555 | 1.00 | PLA2G1B (0.60) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL5502787 | 1.00 | PLA2G1B (0.60) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL2668921 | 1.00 | PLA2G1B (0.60) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL12656375 | 1.00 | PLA2G1B (0.60) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL8980781 | 1.00 | PLA2G1B (0.60) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL5860291 | 1.00 | PLA2G1B (0.60) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11780739-B2 | Method for producing iron oxide magnetic particles, and iron oxide magnetic materials prepared thereby | ZTI BIOSCIENCES CO., LTD. (KR) | 2023-10-10 | — | — | US | claimed |
| US-20210317005-A1 | METHOD FOR PRODUCING IRON OXIDE MAGNETIC PARTICLES, AND IRON OXIDE MAGNETIC MATERIALS PREPARED THEREBY | ZTI BIOSCIENCES CO., LTD. (KR) | 2021-10-14 | — | — | US | claimed |
| US-8815985-B2 | Curable composition | KANEKA CORPORATION (JP) | 2014-08-26 | — | — | US | claimed |
| EP-4691523-A1 | MEDICAL INSTRUMENT, TREATMENT SOLUTION, AND METHOD FOR MANUFACTURING MEDICAL INSTRUMENT | JMS Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| EP-4691607-A1 | DRAW SOLUTE, DRAW SOLUTION, AND WATER TREATMENT METHOD | Nippon Shokubai Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| WO-2025079728-A1 | CURABLE COMPOSITION AND CURED PRODUCT | 株式会社カネカ | 2025-04-17 | — | — | WO | disclosed |
| EP-4536395-A1 | CLAY COMPOSITE SUPPORT-ACTIVATORS AND CATALYST COMPOSITIONS | Formosa Plastics Corporation, U.S.A. (US) | 2025-04-16 | — | — | EP | disclosed |
| WO-2025037878-A1 | IRON OXIDE MAGNETIC PARTICLES COMPRISING AT LEAST ONE RADIOISOTOPE | 주식회사 지티아이바이오사이언스 | 2025-02-20 | — | — | WO | disclosed |
| CN-119278097-A | Clay complex support-activator and catalyst composition | 美国台塑公司 | 2025-01-07 | — | — | CN | disclosed |
| WO-2024258223-A1 | APPARATUS AND METHOD FOR MANUFACTURING NANOPARTICLE COMPOSITION INCLUDING RADIOACTIVE ISOTOPE | 주식회사 지티아이바이오사이언스 | 2024-12-19 | — | — | WO | disclosed |
| EP-1873208-B2 | CURABLE COMPOSITION AND CURED ARTICLE EXCELLENT IN TRANSPARENCY | KANEKA CORP (JP) | 2024-10-09 | — | — | EP | disclosed |
| EP-1566412-A1 | CURABLE COMPOSITION AND METHOD FOR IMPROVING RECOVERY PROPERTIES AND CREEP PROPERTIES | KANEKA CORPORATION (JP) | 2005-08-24 | — | — | EP | disclosed |
| US-20050171315-A1 | Curable composition | KANEKA CORPORATION | 2005-08-04 | — | — | US | disclosed |
| EP-1550701-A1 | ONE-PART CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2005-07-06 | — | — | EP | disclosed |
| EP-1550700-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2005-07-06 | — | — | EP | disclosed |
| US-20040198885-A1 | Curable composition | KANEKA CORPORATION (JP) | 2004-10-07 | — | — | US | disclosed |
| EP-1445287-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2004-08-11 | — | — | EP | disclosed |
| US-5536425-A | DURABILITY | SONY CORPORATION (JP) | 1996-07-16 | — | — | US | disclosed |
| US-5453539-A | Durability | SONY CORPORATION (JP) | 1995-09-26 | — | — | US | disclosed |
| EP-0519406-A2 | Novel perfluoropolyether derivatives, and lubricants and magnetic recording medium using the same | SONY CORPORATION (JP) | 1992-12-23 | — | — | EP | disclosed |